Welcome to LookChem.com Sign In|Join Free
  • or
6-[3-(Benzyl-ethyl-amino)-2-hydroxy-propoxy]-8-methyl-1H-quinolin-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

143268-92-2

Post Buying Request

143268-92-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143268-92-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 143268-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,2,6 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 143268-92:
(8*1)+(7*4)+(6*3)+(5*2)+(4*6)+(3*8)+(2*9)+(1*2)=132
132 % 10 = 2
So 143268-92-2 is a valid CAS Registry Number.

143268-92-2Downstream Products

143268-92-2Relevant academic research and scientific papers

Novel positive inotropic agents: Synthesis and biological activities of 6- (3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives

Fujioka,Teramoto,Mori,Hosokawa,Sumida,Tominaga,Yabuuchi

, p. 3607 - 3612 (2007/10/02)

A series of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinones has been synthesized and evaluated for positive inotropic activity on the canine heart. Some of these derivatives have a potent activity with none or negative chronotropic effect in isolated, blood-perfused dog heart preparations. They also display a high selectivity for positive inotropic effect over chronotropic and vasodilatory effects in anesthetized dogs. (±)-6-[2- Hydroxy-3-[(3-methoxybenzyl)amino]propoxy]-2(1H)-quinolinone (39) and (±)-6- [3-(3,4-dimethoxybenzyl)amino]-2-hydroxypropoxy]-2(1H)-quinolinone (40) were further investigated in conscious dogs. After iv administration, they did not affect heart rate or mean blood pressure at the dose producing a 50% increase in the peak of the first derivative of the left ventricular pressure. The compounds (39, OPC-18750, and 40, OPC-18790) are the most promising agents with desirable biological activities, and now are currently undergoing clinical evaluation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 143268-92-2